Pioglitazone may impair L-DOPA anti-parkinsonian efficacy in the MPTP-lesioned macaque: results of a pilot study.
about
Pioglitazone may impair L-DOPA anti-parkinsonian efficacy in the MPTP-lesioned macaque: results of a pilot study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Pioglitazone may impair L-DOPA ...... que: results of a pilot study.
@en
Pioglitazone may impair L-DOPA ...... que: results of a pilot study.
@nl
type
label
Pioglitazone may impair L-DOPA ...... que: results of a pilot study.
@en
Pioglitazone may impair L-DOPA ...... que: results of a pilot study.
@nl
prefLabel
Pioglitazone may impair L-DOPA ...... que: results of a pilot study.
@en
Pioglitazone may impair L-DOPA ...... que: results of a pilot study.
@nl
P2860
P50
P356
P1433
P1476
Pioglitazone may impair L-DOPA ...... que: results of a pilot study.
@en
P2093
Philippe Huot
P2860
P304
P356
10.1002/SYN.21801
P577
2015-03-01T00:00:00Z